Juliana Hofstätter Azambuja (J H Azambuja, Juliana H Azambuja, Juliana Hofstatter Azambuja)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 9

Top Venues

International journal of molecular sciences

Molecular neurobiology

Cancer immunology, immunotherapy : CII

Cancer chemotherapy and pharmacology

Universidade Federal de Pelotas (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Universidade Federal de Pelotas Mar 01 2011 - Jun 23 2015

Brazil

MSC :: Bioquímica

Publications

Rubia Isler Mancuso, Sara Teresinha Olalla Saad, Juliana Hofstätter Azambuja
Artesunate Switches Monocytes to an Inflammatory Phenotype with the Ability to Kill Leukemic Cells. International journal of molecular sciences 22 (2) (2021)
Juliana Hofstätter Azambuja, R S Schuh, L R Michels, I C Iser, L R Beckenkamp, G G Roliano, G S Lenz, J N Scholl, J Sévigny, M R Wink, M A Stefani, A M O Battastini, F Figueiró, H F Teixeira, E Braganhol
Blockade of CD73 delays glioblastoma growth by modulating the immune environment. Cancer immunology, immunotherapy : CII 69 (9) (2020)
Juliana Hofstätter Azambuja, Nils Ludwig, Saigopalakrishna S Yerneni, Elizandra Braganhol, Theresa L Whiteside
Arginase-1+ Exosomes from Reprogrammed Macrophages Promote Glioblastoma Progression. International journal of molecular sciences 21 (11) (2020)
Juliana Hofstätter Azambuja, R S Schuh, L R Michels, N E Gelsleichter, L R Beckenkamp, G S Lenz, F H de Oliveira, M R Wink, M A Stefani, A M O Battastini, H F Teixeira, E Braganhol
CD73 as a target to improve temozolomide chemotherapy effect in glioblastoma preclinical model. Cancer chemotherapy and pharmacology 85 (6) (2020)
Juliana Hofstätter Azambuja, Nils Ludwig, Elizandra Braganhol, Theresa L Whiteside
Inhibition of the Adenosinergic Pathway in Cancer Rejuvenates Innate and Adaptive Immunity. International journal of molecular sciences 20 (22) (2019)
Juliana Hofstätter Azambuja, R S Schuh, L R Michels, N E Gelsleichter, L R Beckenkamp, I C Iser, G S Lenz, F H de Oliveira, G Venturin, S Greggio, J C daCosta, M R Wink, J Sevigny, M A Stefani, A M O Battastini, H F Teixeira, E Braganhol
Nasal Administration of Cationic Nanoemulsions as CD73-siRNA Delivery System for Glioblastoma Treatment: a New Therapeutical Approach. Molecular neurobiology 57 (2) (2019)
Fernanda C Teixeira, Fernanda Bruxel, Juliana Hofstätter Azambuja, Alexandre M Berenguer, Marco A Stefani, Jean Sévigny, Roselia M Spanevello, Ana M O Battastini, Helder F Teixeira, Elizandra Braganhol
Development and characterization of CD73-siRNA-loaded nanoemulsion: effect on C6 glioma cells and primary astrocytes. Pharmaceutical development and technology 25 (4) (2019)
Elita Ferreira da Silveira, Luana Mota Ferreira, Mailine Gehrcke, Letícia Cruz, Nathália Stark Pedra, Priscila Treptow Ramos, Natália Pontes Bona, Mayara Sandrielly Pereira Soares, Rodrigo Rodrigues, Rosélia Maria Spanevello, Wilson Cunico, Francieli M Stefanello, Juliana Hofstätter Azambuja, Ana Paula Horn, Elizandra Braganhol
2-(2-Methoxyphenyl)-3-((Piperidin-1-yl)ethyl)thiazolidin-4-One-Loaded Polymeric Nanocapsules: In Vitro Antiglioma Activity and In Vivo Toxicity Evaluation. Cellular and molecular neurobiology 39 (6) (2019)
Juliana Hofstätter Azambuja, N E Gelsleichter, L R Beckenkamp, I C Iser, M C Fernandes, F Figueiró, A M O Battastini, J N Scholl, F H de Oliveira, R M Spanevello, Jean Sévigny, M R Wink, M A Stefani, H F Teixeira, Elizandra Braganhol
CD73 Downregulation Decreases In Vitro and In Vivo Glioblastoma Growth. Molecular neurobiology 56 (5) (2018)

Juliana Hofstätter Azambuja.css-eqlu8i{font-size:small;padding-left:4px;} (J H Azambuja, Juliana H Azambuja, Juliana Hofstatter Azambuja)

Publication Activity (10 Years)

Top Topics

Top Venues

Juliana Hofstätter Azambuja (J H Azambuja, Juliana H Azambuja, Juliana Hofstatter Azambuja)